Ignite Creation Date:
2024-05-06 @ 10:35 AM
Last Modification Date:
2024-10-26 @ 12:32 PM
Study NCT ID:
NCT03293134
Status:
COMPLETED
Last Update Posted:
2017-09-26
First Post:
2017-05-02
Brief Title:
Clinical and Molecular Characterization of Cerebral Proliferative Vasculopathy
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Assistance Publique - Hôpitaux de Paris
Study Overview
Official Title:
Clinical and Molecular Characterization of Cerebral Proliferative Vasculopathy
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VPCA
Brief Summary:
As principal objective the study aims to
1 Describe the spectrum and evaluate the frequency of angiodysplasia of the nevrax
2 Establish the physiopathological basis of Fowlers syndrome
3 Identify FLVCR2 partners and the signaling pathways involved
4 Test new candidate genes GPR124 and possible partners of FLVCR2
As second objective the study aims to
perform phenotype genotype correlation if necessary
and propose a prenatal diagnosis in families with identified mutations
1 Describe the spectrum and evaluate the frequency of angiodysplasia of the nevrax
2 Establish the physiopathological basis of Fowlers syndrome
3 Identify FLVCR2 partners and the signaling pathways involved
4 Test new candidate genes GPR124 and possible partners of FLVCR2
As second objective the study aims to
perform phenotype genotype correlation if necessary
and propose a prenatal diagnosis in families with identified mutations
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None